missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Sutimlimab Recombinant Monoclonal Antibody
Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA558457
This item is not returnable.
View return policy
Description
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Sutimlimab is an anti-C1s antibody. Studies have shown that it can significantly increase hemoglobin levels in patients with primary cold agglutinin disease. Cold agglutinin disease (CAD) is a type of acquired autoimmune hemolytic anemia (AIHA). In cold environments, cold parts of the body will have clinical symptoms related to red blood cell aggregation (for example, the Internet Plaque or cyanosis) and hemolytic anemia.
Specifications
| Sutimlimab Humanized | |
| Recombinant Monoclonal | |
| Unconjugated | |
| BIVV009; IPN-009; TNT009 | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG4SP |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Human | |
| 100 μg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction